收藏切换
Stimuli-activatable PROTAC for precise cancer therapy
收藏切换
Xing-yu JIANG, Yi-nuo CHEN, Wan-xu ZHANG, Zhi-ai XU*
Acta Pharmaceutica Sinica | 2025, 60(11) : 3263 - 3282
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(11): 3263-3282
• Special Reports: Recent advances in targeted protein degradation therapeutics •
Stimuli-activatable PROTAC for precise cancer therapy
Full
Xing-yu JIANG, Yi-nuo CHEN, Wan-xu ZHANG, Zhi-ai XU*
Affiliations
  • School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, China
Published: 2025-11-12 doi: 10.16438/j.0513-4870.2025-0540
Outline
收藏切换

Proteolysis-targeting chimeras (PROTACs) leverage their "event-driven" mechanism to target traditionally undruggable proteins inaccessible to conventional small molecule inhibitors, thereby significantly expanding the therapeutic landscape of drug discovery. Furthermore, PROTACs overcome the resistance associated with small molecule inhibitors by achieving complete degradation of target proteins rather than transient functional inhibition. However, their sustained catalytic activity may induce off-target effects and systemic toxicity. To mitigate these limitations, stimuli-responsive PROTAC prodrug systems have emerged as a promising strategy to spatiotemporally control PROTAC activation within tumor microenvironments. PROTAC prodrug systems demonstrate tumor microenvironment-responsive activation through endogenous/exogenous stimuli (e.g., light, enzymes, reactive oxygen species), enabling spatiotemporal control of PROTAC liberation. This precision engineering strategy significantly reduces off-target toxicity while maintaining potent on-target protein degradation efficacy. This review provides a systematic overview of cutting-edge advances in stimuli-activatable PROTAC platforms, critically examines current limitations and challenges in the field, and proposes strategic directions for future development to accelerate the evolution of precision cancer therapeutics.

stimuli-activatable prodrug  /  PROTAC  /  protein degradation  /  cancer  /  precision therapy
江幸羽, 陈奕诺, 张琬絮, 徐志爱. 刺激响应型PROTAC用于肿瘤精准治疗. 药学学报, 2025 , 60 (11) : 3263 -3282 . DOI: 10.16438/j.0513-4870.2025-0540
Xing-yu JIANG, Yi-nuo CHEN, Wan-xu ZHANG, Zhi-ai XU. Stimuli-activatable PROTAC for precise cancer therapy[J]. Acta Pharmaceutica Sinica, 2025 , 60 (11) : 3263 -3282 . DOI: 10.16438/j.0513-4870.2025-0540
Year 2025 volume 60 Issue 11
349
173
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0540
  • Receive Date:2025-05-12
  • Online Date:2026-09-20
  • Published:2025-11-12
Article Data
Affiliations
History
  • Received:2025-05-12
  • Revised:2025-07-24
Affiliations
    School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0540
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT